Related Experiment Video
Updated: Nov 5, 2025

10:32
Organotypic Retinal Explant Cultures from Macaque Monkey
Published on: August 24, 2022
1.5K
Retinal Damage in Amyotrophic Lateral Sclerosis: Underlying Mechanisms
Vladislav O Soldatov1,2, Michail S Kukharsky3,4, Andrey E Belykh5
1Core Facility Centre, Institute of Gene Biology, Russian Academy of Sciences, Moscow, Russia.
Eye and Brain
|May 20, 2021
Summary
Amyotrophic lateral sclerosis (ALS) affects the retina, showing similar neurodegenerative changes as the spinal cord. Understanding these neuro-ophthalmic interactions may aid in ALS diagnosis and treatment.
Area of Science:
- Neuroscience
- Ophthalmology
- Genetics
Background:
- Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease primarily affecting motor neurons.
- Ophthalmic complaints are not classic ALS symptoms, but retinal changes are observed in patients.
- The retina shares developmental and genetic links with the brain, making it susceptible to neurodegeneration.
Purpose of the Study:
- To investigate the impact of ALS on retinal cells.
- To explore shared molecular pathways between motor neuron degeneration and retinal abnormalities in ALS.
- To assess the potential of neuro-ophthalmic interactions for ALS diagnosis and treatment.
Main Methods:
- Review of existing literature on ALS pathology and retinal changes.
- Analysis of experimental studies on ALS-related molecular mechanisms.
- Comparison of cellular changes in the retina and spinal cord in ALS models.
Main Results:
- ALS affects multiple vulnerable pathways in retinal cells, mirroring those in motor neurons.
- Pathways implicated include aggregate deposition, impaired protein import, ER stress, excitotoxicity, vascular regression, and mitochondrial dysfunction.
- Retinal abnormalities in ALS patients and models resemble spinal cord pathology.
Conclusions:
- The retina is significantly affected by ALS through shared pathogenic mechanisms with motor neurons.
- Neuro-ophthalmic findings in ALS offer potential biomarkers for early diagnosis.
- Targeting shared pathways may lead to novel therapeutic strategies for ALS.
More Related Videos
Related Concept Videos
Parkinson's Disease: Overview
1.0K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.0K
Cross-bridge Cycle
120.0K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
120.0K

